We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNFI icon
1151
United Natural Foods
UNFI
$2.85B
$68K 0.01%
7,796
-6,976
-47% -$56.2K
BBBY
1152
DELISTED
Bed Bath & Beyond Inc
BBBY
$68K 0.01%
3,936
+2,937
+294% +$41.1K
CRON
1153
Cronos Group
CRON
$1.14B
$67K 0.01%
8,736
+8,436
+2,812% +$64.5K
EBF icon
1154
Ennis
EBF
$564M
$67K 0.01%
3,103
+3,067
+8,519% +$62.4K
ENR icon
1155
Energizer
ENR
$1.55B
$67K 0.01%
1,334
-6,128
-82% -$282K
GHC icon
1156
Graham Holdings Company
GHC
$5.02B
$67K 0.01%
104
+69
+197% +$44.1K
POST icon
1157
Post Holdings
POST
$3.57B
$67K 0.01%
941
+296
+46% +$20.3K
PVH icon
1158
PVH
PVH
$4.04B
$67K 0.01%
637
-2,734
-81% -$261K
SJM icon
1159
J.M. Smucker
SJM
$12.8B
$67K 0.01%
644
-954
-60% -$101K
WTFC icon
1160
Wintrust Financial
WTFC
$10.7B
$67K 0.01%
952
+778
+447% +$51.8K
PRVL
1161
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$67K 0.01%
+4,206
New +$53.6K
DLPH
1162
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$67K 0.01%
5,204
+4,354
+512% +$56.4K
UN
1163
DELISTED
Unilever NV New York Registry Shares
UN
$67K 0.01%
1,166
-469
-29% -$27.7K
COLB icon
1164
Columbia Banking Systems
COLB
$8.84B
$66K 0.01%
1,612
+1,024
+174% +$39.9K
DXC icon
1165
DXC Technology
DXC
$1.73B
$66K 0.01%
1,741
-22,429
-93% -$732K
HEFA icon
1166
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.71B
$66K 0.01%
2,158
-131
-6% -$4K
MOMO
1167
Hello Group
MOMO
$866M
$66K 0.01%
1,972
-6,147
-76% -$219K
XLRN
1168
DELISTED
Acceleron Pharma
XLRN
$66K 0.01%
1,237
+1,048
+554% +$47.8K
EV
1169
DELISTED
Eaton Vance Corp.
EV
$66K 0.01%
1,422
-4,327
-75% -$200K
ALB icon
1170
Albemarle
ALB
$15.5B
$65K 0.01%
889
-3,772
-81% -$252K
GSY icon
1171
Invesco Ultra Short Duration ETF
GSY
$3.9B
$65K 0.01%
+1,300
New +$65.5K
HOG icon
1172
Harley-Davidson
HOG
$2.71B
$65K 0.01%
1,758
-7,741
-81% -$288K
KRYS icon
1173
Krystal Biotech
KRYS
$9.66B
$65K 0.01%
1,180
+497
+73% +$24.4K
UUP icon
1174
Invesco DB US Dollar Index Bullish Fund
UUP
$422M
$65K 0.01%
+2,500
New +$66.8K
WSBC icon
1175
WesBanco
WSBC
$4B
$65K 0.01%
1,717
+1,560
+994% +$58.3K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.